Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 282Gynecologic 110Breast 64Head & Neck 31CNS 30Genitourinary 27Gastrointestinal 21Other solid neoplasm 10Tumor-Agnostic 8Lymphoid 6Sarcoma 5Dermatologic 4Endocrine 2Other 1Classical hematology 1

Conditions

Obesity 1Neurotoxicity Syndromes 1Fatigue 1

Interventions

naloxegol 5Metformin 4alvimopan 3Radiotherapy 3tegaserod 2Testosterone Propionate 2Surveys and Questionnaires 2Standard of Care 2Liraglutide 2Glutamine 2Fibroblast Growth Factor 7 2Exenatide 2Early Intervention, Educational 2semaglutide 1prucalopride 1oxycodone-acetaminophen 1oxycodone naloxone combination 1lime 1dapagliflozin 1cyclohexaneacetic acid 1bicalutamide 1acetaminophen, hydrocodone drug combination 1Testosterone 1Taxes 1Tamoxifen 1Tadalafil 1Sugars 1Sugammadex 1Sucralfate 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carboplatin × Other × Clear all
NCT00807768 2019-03-20

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

GOG Foundation

Phase 3 Unknown
601 enrolled 13 charts
Other

Fatigue, Obesity, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡